Satavaptan (SR121463) ( DrugBank: Satavaptan )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
72下垂体性ADH分泌異常症1

72. 下垂体性ADH分泌異常症


臨床試験数 : 41 薬物数 : 27 - (DrugBank : 8) / 標的遺伝子数 : 7 - 標的パスウェイ数 : 10
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00728091
(ClinicalTrials.gov)
July 200831/7/2008A Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaA Double-Blind, Randomized, Placebo-Controlled Multicenter Study Evaluating the Efficacy and Safety of Two Doses of Satavaptan (SR121463B) Versus Placebo in Patients With Dilutional Hyponatremia Due to the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)Hyponatremia;Inappropriate ADH SyndromeDrug: satavaptan (SR121463);Drug: placeboSanofiNULLTerminated18 YearsN/ABoth2Phase 3United States